Fund HoldingsKrensavage Asset Management, LLC

Total Portfolio Value
$217.8K
Total Bought
$9.3K
Total Sold
$10.8K
Net Transaction
-$1.5K
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
VANDA PHARMACEUTICALS INC0662,166+662,166041.72%+4
UNITED THERAPEUTICS CORP(UTHR)156,714118,208-38,506363817.29%+2
EXELIXIS INC(EXEL)1,566,1401,677,393+111,253373817.31%+1
TARO PHARMACEUTICAL INDUS647,868650,089+2,221272812.83%+1
SANOFI-ADR(SNY)150,959153,832+2,873773.43%0
MURAL ONCOLOGY PLC88,00175,057-12,944000.11%-0
BIOGEN INC(BIIB)134,068123,785-10,283292913.18%-0
BIONTECH SE-ADR(BNTX)120,000132,293+12,29311114.88%-0
JAZZ PHARMACEUTICALS PLC(JAZZ)101,151109,076+7,92512125.35%-1
ALKERMES PLC(ALKS)257,554257,5540762.85%-1
ENANTA PHARMACEUTICALS INC1,124,5861,251,338+126,75220167.45%-3
REGENERON PHARMACEUTICALS(REGN)12,4947,853-4,6411283.79%-4
CARDINAL HEALTH INC(CAH)235,656217,656-18,00026219.83%-5
Page 1 of 1